AusBiotech is offering a list of optional activities for Tuesday 23 May. You can opt in for one of the options below during the registration process

 

Medical Technology Research Institute Tour*

10:00am - 4:00pm

The Medical Technology Research Institute Tour will explore some of the world’s leading medical research institutes including the Bionics Institute, the St Vincent's Institute of Medical Research and the newly-developed Aikenhead Centre for Medical Discover (ACMD) research facility, BioFab3D@ACMD. Together these institutes provide a unique model for collaboration between researchers, clinicians, end-users and industry in Melbourne’s CBD.

This tour will provide the opportunity to:

  • Visit cutting-edge institutes and centres
  • View research, facilities and capabilities within Melbourne’s CBD
  • Meet academics driving the latest medical technology research

*The tour is not included in the conference registration. You can register for the tour during the registration process for an additional $15

 

Inaugural ANDHealth AusBiotech Digital Health summit

Location: Allens Linklaters, 101 Collins St, Level 37, Melbourne, 3000, VIC

8:30am - 6:30pm

ANDHealth, Australia’s national digital health integrator and accelerator, is running a one-day digital health summit in conjunction with AusBiotech on 23 May. Join the community for excellent networking sessions between speakers:

 

  • Hear practical information and insights from the leaders in digital health;
  • Investor perspectives;
  • Company success stories;
  • Regulatory information; and
  • Access to Australia’s leading digital health entrepreneurs.

 

View the full program and register here

Regulatory affairs and health economics workshop

Location:  Griffith Hack, 10/161 Collins St, Melbourne VIC 3000

9:30am - 5:30pm

AusMedtech, the national industry group representing the medical devices and diagnostics industry sector in Australia, invites you to attend the Regulatory Affairs and Health Economics Workshop at AusMedtech 2017 & ICMMB 2017.

While Australia boasts a strong market for developing medical technology, yet the landscape is complex and dynamic. This workshop will explore this landscape, presenting current trends and emerging issues that may affect organisations operating in the medical device industry.

The AusMedtech Regulatory Affairs Expert Panel will lead the morning session, focusing on the Therapeutic Goods Administration (TGA)’s Medicines and Medical Devices Review (MMDR), changes in the European Union (EU) and provide an overview of risk classification.

The afternoon session, led by the Health Economics Expert Panel, will discuss prostheses prices and continuing reform of private health insurance. 

View the full program and register here

 

Phillips Ormonde Fitzpatrick wine tasting event

6:00 - 8:00pm

Enjoy a relaxed evening of wine tasting, followed by a networking session hosted by Phillips Ormonde Fitzpatrick at their Melbourne office 

Space is limited, please express your interest during the registration process

9:00 - 9:30am

Arrival and registration for AusMedtech 2017 & ICMMB 2017

9:30 - 10:00am 
Official conference welcome
Room: Promenade

 

Richard Bolt, Secretary to the Department of Economic Development, Jobs, Transport and Resources

Glenn Cross, AusBiotech, CEO

Yosry Morsi, ICMMB Chair

 
             
                            

10:00 - 11:00am

 

Plenary: The Bionic Eye: Restoring sight with vision prostheses

Room: Promenade

 

The bionic eye aims to deliver functional vision and improved quality of life for patients with degenerative vision loss caused by conditions such as retinitis pigmentosa and age-related macular degeneration. This talk will present recent developments and the challenges associated with providing clinically safe and commercially competitive technologies to provide functional everyday benefits to patients. The Bionic Vision Australia research program, which has developed a fully implantable device that is based upon the successful prototype study with three patients, will be outlined.

 

Prof Anthony N Burkitt, Director, Bionic Vision Australia, University of Melbourne 

11:00 - 12:00pm

 

Plenary: We are such stuff as dreams are made on

Room: Promenade

 

The concept of harnessing the power of science and technology to deliver personalised medical solutions for trauma, tumour, degeneration, and disease has become an irresistible quest that has galvanised scientists and clinicians. The rapid advances in technology has enabled scientific discovery, greater innovation and more significant impact of treatments.

 

Prof Peter Choong, Sir Hugh Devine Professor of Surgery, University of Melbourne Director of Orthopaedics, St. Vincent’s Hospital Melbourne

12:00 - 1:00pm

Lunch and networking with exhibitors

‘Meet the AusMedtech Regulatory Affairs Expert Panel’ networking lunch 

 

AusMedtech breakout sessions

ICMMB breakout sessions

1:00 - 2:00pm

Emerging technologies

Room: M1&2

From professional kitesurfing to human exoskeletal design, from skin patrol to digital health, and from the first female President of the Medical Software Industry Association to cloud based chronic disease management, these three speakers will share the insights of their journey and the development of some very exciting emerging technologies

 

Chair: Warren Bingham, VP Asia Pacific, Clinical Genomics

 

Dr Gil Stynes, Department of Surgery, St. Vincent’s Hospital, University of Melbourne

 

Jenny O’Neill, CEO and co-founder, Episoft 

 

Samuel Holt, Founder, Skinview

Changes in the regulatory landscape

Room: M3&4

Implementation of recommendations from the Review of Medicines and Medical Devices Regulation report

 

Chair: Grant Bennet, CEO, Brandwood Biomedical

 

Adjunct Prof John Skerritt, Deputy Secretary, Health Products Regulation Group, Department of Health 

 

Panel discussion:

 

Dushyant Sanathara, BDM, Medical Devices and Product Certification, BSI 

 

Dr Darren Forrest, Director of Quality and Regulatory Affairs ANZ, Medtronic

 

Dr Frederic Bustos, Quality and Regulatory Affairs Manager, Cochlear  

Biomaterials and tissue engineering - Part 1

Room: M7&8 

 

Chair: Prof Xiumei Mo, Donghau University, China  

 

Dr Ivan Corazza, University of Bologna, Italy

Low gradient severe aortic stenosis: how is it possible? 

 

Tonghe Zhu, Donghua University, Shangai, China

Braid-reinforced nanofibrous small diameter vascular grafts for potential vascular tissue reconstruction 

 

Prof Simon Moulton, Swinburne University of Technology, Australia

Biofabrication for drug delivery

 

Pier Luca Rossi, University of Bologna, Italy

Mechanical and radiological aspects of carbon dioxide coronal angiography: a study of feasibility

Advances in stem cell therapies – Part 1

Room: M9&10

 

Chair: Prof David Liley, Swinburne University of Technology, Australia

 

Keynote speaker: Prof Samira Musah, Harvard University (USA)

Stem cell-based model of human organ development and function

 

Prof Ramakrishnan Swaminathan, Indian Institute of Technology, India

Analysis of fatigue on biceps brachii muscles using SEMG signals and spline chirplet transformation 

 

2:00-3:00pm

Business models for medical technologies

Room: M1&2

Hear about the business models and strategies organisations have taken to bring a technology from discovery to market. From early stage licensing, to acquisition to ASX listing

 

Chair: Peter Bradley, VP Global Business Development, LBT Innovations  

 

Phoebe Macleod, Head of Legal and Licensing, Digital Health, MCRI 

 

Nick Haan, Executive Director, OncoDx

 

Liza Dunne, CEO, OncoRes Medical

 

Jenny O’Neill, CEO and co-founder, Episoft 

Medical device clinical trials: Developments in the Australian landscape

Room: M3&4

 

Chair: Lorraine Chiroiu, Deputy CEO, AusBiotech

 

Sue MacLeman, CEO & Managing Director, MTPConnect

Measuring the economic value of CTs: MTPConnect's work to support the Industry

 

Lyndon Crossley, Director of Clinical Affairs, Global Orthopaedic Technology

The evolving nature of CTs for post-market regulation and reimbursement in light of new technologies

 

Adele Hosseini, Director of Clinical Affairs

The new normal: Case study on CTs in non-typical circumstances

 

Kylie Sproston, Chief Executive, Bellberry Limited

NHMRC National Scientific Committees & their role with clinical trials

 

Dr David Lloyd, Managing Director, Southern Star Research

Future outlook for CTs in Australia

 

Biomaterials and tissue engineering - Part 2

Room: M7&8 

 

Chair: Prof Samira Musah, Harvard University

 

Keynote speaker: Dr Yasuhiko Tabata, Kyoto University, Japan

Tissue engineering of biomaterials technology to realise regeneration medicine 

 

Lilith Caballero Aguilar, Swinburne University of Technology, Australia

Preparation and characterisation of polycaprolactone-alginate microspheres for drug delivery 

 

Shaun Gietman, Swinburne University of Technology, Australia

Synthesis of optically active drug delivery systems 

Medical, rehabilitation robotics and assistive devices - Part 1

Room: M9&10

 

Chair: Prof Paul Stoddart, Swimburne University of Technology, Australia

 

Keynote speaker: Prof Romano Zannoli, University of Bologna, Italy

When you need, it never works : incongruence between technological solutions and clinical  needs

 

Dr Boyin Ding, The University of Adelaide, Australia

The impact of 6DOF loading speed on the viscoelastic behaviour of the femur 

 

Ben Allardyce, Deakin University, Australia

Silk membranes with suitable mechanical, vibrational and degradation properties for the repair of chronic perforations of the tympanic membrane 

 

 

3:00 - 3:45pm

Afternoon tea and networking with exhibitors

3:45 - 4:45pm

Overcoming barriers to global market access

Room: M1&2

Barriers to overcome to access market:

- Regulatory / Clinical trials

- Reimbursement

- Distribution

- Cultural barriers

 

Chair: Brendan Mason, Managing Director, Sino-Oz 

 

Johanna Wright, Director of Regulatory Affairs, ResMed

 

Simranjit Singh, General Manager, Medical Devices & Diagnostics Asia, QuintilesIMS

 

Mike Heyl, Partner, Hogan Lovells

 

 

Is the company investable?

Room: M3&4

IP and related issues from company, investor and adviser perspectives

 

Chair: Rob McInnes, Partner, DibbsBarker

 

Peter Franke, Principal, Franke Hyland

 

Brigitte Smith, Managing Director, GBS Venture Partners

 

Dr Abby Bloom, Executive Chair, Acu Rate Pty Ltd 

 

Electrospinning– Part 1

Room: M7&8

 

Chair: Prof Yosry Morsi, Swinburne University of Technology, Australia 

 

Keynote speaker: Prof Xiumei Mo, Donghau University, China

Electrospun 3D porous nanofibre scaffolds for ligament and cartilage tissue engineering

 

Binbin Sun, Donghua University, Shanghai, China

Polypyrole-coated nanofibrous membranes promoting neural cells proliferation and differentiation with electrical stimulation

 

Riyadh Al-Attabi, Swinburne University of Technology, Australia

The use of electrospun nanofibers membranes for the removal viruses and bacteria from air 

 

 

Neuroscience and neuroengineering - Part 1

Room: M9&10

 

Chair: Prof David Liley, Swinburne University of Technology, Australia

 

Keynote speaker: Prof Rikky Muller, University of California, USA

 

William Hart, Swinburne University of Technology, Australia

Modelling the optical stimulation of nerve electrical activity

 

Vidhusha Srinivasan, SSN College of Engineering, India

Speech imagery based vowel classification using brain connectivity estimators and machine learning techniques 

4:45 - 5:45pm

Delivering on the potential of digital health

Room: M1&2

Digital health is creating a buzz but can it deliver on its potential? Hear about how these organisations are approaching digital health and realising its promise across pharmaceuticals, research and healthcare delivery

 

Chair: Phoebe Macleod, Head of Legal and Licensing, Digital Health, MCRI

 

Adam Wardell, Head of Strategy, Innovation and BD&L, Novartis

 

Dr Rob Grenfell, Health Director, CSIRO Health and Biosecurity

 

George Papadopoulos, Managing Director, Emerald Corporate Group  

The policy and politics of reimbursement of medical devices in Australia

Room: M3&4

Achieving reimbursement of new medical services and devices requires sponsors and applicants to navigate the demands of multiple stakeholders including patients, clinicians, politicians and bureaucrats. This session will discuss the practicalities and pitfalls of this process

 

Chair: Dominic Tilden, Director, Thema Consulting

 

Keynote speaker: Tracey Duffy, Assistant Secretary Private Health Insurance, Department of Health 

 

Panel discussion:

 

Sarah Griffin , Principal Consultant Health Economics and Reimbursement, Brandwood Biomedical

 

Dan Barker, Chief Technology Officer, Global Orthopaedic Technology

 

Mark Muller, CFO, Cook Medical  

Medical, rehabilitation robotics and assistive devices - Part 2

Room: M7&8

 

Chair: Prof Romano Zannoli, University of Bologna, Italy

 

Keynote speaker: Prof Yosry Morsi, Swinburne University of Technology, Australia 

 

Eric Wu, University of Queensland, Australia

Talking heart to heart: towards an intelligent rotary blood pump 

 

Shih-Yun Lin, National Cheng Kung University, Taiwan

Design and stiffness analysis of new designed rocker shoe soles

 

Biomechanics and computer modeling/simulation - Part 1

Room: M9&10

 

Chair: Prof Cheng-Kung Cheng, National Yang-Ming University, Taiwan

 

Fernando Jativa, University of Melbourne, Australia

Biomechanics and functionality of human lung 3D smooth muscle and fibroblast spheroids 

 

Ashish Saxena, Nanyang Technological University, Singapore

Venous blood flow characterisation in a human forearm 

 

Dr Kheng Lim Goh, Newcastle University International, Singapore

Structure and functional significance of extracellular matrix scaffolds derived from the common sea urchin tissue

 

Prof Cheng-Kung Cheng, National Yang-Ming University, Taiwan

Biomechanical evaluation of a novel pedicle screw-based interspinous spacer: A finite element analysis 

5:45 - 7.00pm

Iverson Health Innovations Research Institute Launch Event - Pre-Dinner Drinks

Room: Promenade foyer area

Supported by:

   

 

7:00 - 10:00pm

AusMedtech Cook Conference Dinner

Room: Promenade

 

      

 

7:45 - 8:45am

Australian National Fabrication Facility (ANFF) business breakfast

Room: M1&2

Research leaders from ANFF community will provide an update on emerging medical technologies. It will also provide a perspective on how a company can run a research program without significant investments in their own infrastructure.

 

Chair: Dr Warren McKenzie, Business Development Manager, Australian National Fabrication Facility (ANFF)

 

Prof Nico Voelcker, Director Victorian Node of ANFF, Melbourne Centre for Nanofabrication, Monash University, CSIRO Manufacturing

 

Prof Sally McArthur, Swinburne University of Technology and OCE Science Leader CSIRO Manufacturing

 

Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical

 

 

8:30 - 9:00am

Registration desk opens

9:00 - 9:45am

CEO panel session: What keeps you awake at night?

Room: Promenade

 

Chair: Lusia Guthrie, Chairman, Clever Culture Systems

 

Peter Rowland, Managing Director, Micro-X Ltd

 

Michael Kavanagh, CEO and President, Nanosonics

 

Stuart Elliott, CEO, Planet Innovation

 

Matthew Hoskin, CEO, Sienna Cancer Diagnostics 

 

Julie-Anne Quinn, CEO, Bionic vision Technologies

 

ICMMB Plenary

Room: M7&8

 

Chair: Dr Yasuhiko Tabata, Kyoto University, Japan

 

Keynote speaker: Prof Cheng-Kung Cheng, Chair Professor of Department of Biomedical Engineering and Director of Orthopaedic Device Research Center, National Yang Ming University; Chairman, Board of Directors of Digital Orthopaedic Foundation of Chinese Speaking Orthopaedic Society

Translational research of biomechanics: from clinical observations to clinical solutions 

 

9:45 - 10:20am

 

The Biomedical Translation Fund panel update

Room: Promenade

The Biomedical Translation Fund (BTF) is designed to support biotech through the two funding “valleys of death”, providing $500 million to be invested in the biotech sector. With the recent announcement of BTF fund managers, this panel will provide an update and explore how the BTF will stimulate private sector investment

 

Chair: Peter Wills AC, Chair, BTF Committee  

 

Graeme Wald, Principal, OneVentures

 

Dr Chris Nave, Managing Director, Brandon Capital Partners

 

Dr Amanda Gillon, Investment Manager, BioScience Managers

 

Yasser El-Ansary, CEO, AVCAL

ICMMB Plenary

Room: M7&8

 

Chair: Prof Yosry Morsi, Swinburne University of Technology, Australia

 

Keynote speaker: Dr Eiji Matsuura, Okayama University, Japan

Harnessing disease-specific antibody and its variant in “theranostics” of cancer

10:20 - 10:50am

Morning tea

10:50 - 12:00pm

Partnering on product design and deals

Room: Promenade

 

Chair: Dr Kerry A. Hegarty, Business Development Director, Research, Innovation & Commercialisation, The University of Melbourne

 

Timothy I. Still, President and CEO, Global Kinetics Corporation 

Utilising Digital Health to deliver on the promise of Personalised Medicine: A case study of the Parkinson’s KinetiGraph™ and the benefits it provides to patients, partners and payors

 

Nick Pachuda, VP External Innovation Orthopedics & Kathy Connell, Senior Director New Ventures, ANZ, Johnson & Jonhson Innovation

Case study: J&J Orthocell agreement

 

Dr Nicholas Opie, Founding Director and CTO, SmartStent and Senior Research Fellow, The University of Melbourne

Stentrode – The Next Generation Brain Machine Interface

Biomechanics and computer modeling/simulation - Part 2

Room: 7&8

 

Chair: Prof Yosry Morsi, Swinburne University of Technology, Australia

 

Keynote speaker: Prof Fong-Chin Su, National Cheng Kung University, Taiwan

Biomechanical concepts for rehabilitation of knee osteoarthritis using a novel pinnacle trainer

 

Siamak Nezami Doost, Swinburne University of Technology, Australia

Using computational fluid dynamics to visualise blood flow of a patient-specific left ventricle 

 

Tejas Canchi, Nanyang Technological University, Singapore

Effect of patient history on estimation of rpture risk in Asian Abdominal Aortic Aneurysm (AAA) patients using machine learning methods 

Bioprinting and biofabrication

Room: 9&10

 

Chair: Prof Simon Moulton, Professor of Biomedical Electromaterials, Swinburne University of Technology 

 

A/Prof Andrea J. O’Connor, The University of Melbourne, Australia

Magnetic regulation of forces and cell assembly for tissue engineering 

 

Holger Pils, Bio-Strategy PTY Ltd, Australia

3D-bio-printing and nano-dispensing devices for tissue engineering 

 

Dr Kara Vine, University of Wollongong, Australia

Changing the treatment paradigm: Ex vivo assessment of gemcitabine-Eluting degradable polymeric fibres for the treatment of pancreatic ductal adenocarcinoma

12:00 - 1:00pm

Collaboration for commercialisation

Room: M1&2

Collaboration is the often touted as the key to successful commercialisation.  Is this true for medtech? What works and what are the gaps in the Australian ecosystem?  This session will discuss the challenges faced and factors for success in collaborating to commercialise medical technologies, including perspectives from government, industry and academia.    

 

Chair: Dr Joanne Boag, Head of IP and Licensing, Biotech and Medtech, MCRI

 

Panel discussion:

 

James Macnaughtan, Director New Technologies APAC, Cook Medical

 

Andrew Murphy, Director of international Digital Health network HealthXL

 

Dr Charlie Day, CEO, Office of Innovation and Science Australia

New IP Ready online tool (10 min presentation)

Room: M3&4

 

Rob McInnes, Partner, DibbsBarker

Biomechanics and computer modeling/simulation - Part 3

Room: M7&8 

 

Chair: Prof Samira Musah, Harvard University, USA

 

Keynote speaker: Prof Itsu Sen (Yi Qian), Macquarie University, Australia

 

Yuanyuan Dai, Macquarie University, Australia.

Hemodynamics Analysis for carotid artery before and after carotid endarterectomy 

 

Gayan Weerakkody Dayarathnage, Swinburne University of technology, Australia

Fluid structure interaction of the mechanical heart valve incorporating thoracic aortic aneurysm

Advances in stem cell therapies - Part 2

Room: 9&10

 

Chair: Dr Kara Vine, University of Wollongong, Australia

 

Keynote speaker: Prof Paul Verma, Monash Institute of Medical Research, Australia

 

Nagarajan Ganapathy, Indian Institute of Technology, India

Emotion analysis using electrodermal activity signals and dynamic restricted Boltzmann machines

 

Sandhya Sundaram, Indian Institute of Technology

Objective assessment of lymphocyte response across molecular subtypes of Breast carcinoma

What is Goverment policy on medtech?

Room: M3&4

 

Chair: Lorraine Chiroiu, Deputy CEO, AusBiotech

 

Andrew Wear, Director, Medical Technologies and Pharmaceuticals Department of Economic Development, Jobs, Transport and Resources 

 

Marco Baccanti, Chief Executive, Health Industries South Australia

1:00 - 2:00pm

Lunch

1:00 - 2:00pm

IP Australia - Patent Analytics Hub for businesses

Room: M1&2                                

2:00 - 2:45pm

Risk process for medical device development and commercialisation

Room: Promenade

How and why it is best to take a risk driven approach when commercialising technology. Presenting a case study: research developed at the University of Western Australia, taken through the commercialisation process into a start-up vehicle OncoRes, raising capital via Brandon Capital

 

Chair and keynote speaker: Toby McSweeney, Head of Class III Development Group, Hydrix

 

Panel discussion:

 

Liza Dunne, CEO, OncoRes Medical

 

Kath Giles, Investment Manager, Brandon Capital

 

Dr Brendan Kennedy, Laboratory Head, Harry Perkins Institute of Medical Research & Senior Research Fellow, The University of Western Australia & Chief Scientific Officer, OncoRes Medical.

 

ICMMB Plenary

Room: M7&8

 

Chair: Dr Yasuhiko Tabata, Kyoto University, Japan

 

Keynote speaker: Prof Anthony Weiss, University of Sydney, Australia

2:45 - 3:25pm

Update on the Federal Government's Growth Centres

Receive an update on the Industry Growth Centres, an industry-led approach driving innovation, productivity and competitiveness by focusing on areas of competitive strength and strategic priority, which include advanced manufacturing and medical technologies and pharmaceuticals. 

Room: Promenade

 

Chair: Glenn Cross, CEO, AusBiotech

 

Sue MacLeman, CEO and Managing Director, MTPConnect

 

Michael Grogan, Victorian Director, Advanced Manufacturing Growth Centre 

 

Advances in medical devices - Design and optimisation

Room: 7&8

 

Chair: David Liley, Swinburne University of Technology, Australia

 

Keynote speaker: Dr Dan Abrams, Cerebral Therapeutics 

Creating value in central nervous system startups

 

Don Bombuwela, Swinburne University of Technology, Australia

Improved wireless cyclic pressure ventricular assist device (Cy-VAD) 

 

Philip Kinsella, Swinburne University of Technology, Australia

Automated design of custom-fit in-ear devices from 3D scan data  

 

Biomaterials

Room: 9&10

 

Chair: Prof Xiumei Mo, Donghau University, China

 

Prof Paul R. Stoddart, Swinburne University of Technology, Australia

Dynamic mechanical properties of PDMS measured on the mesoscale with an ptical fibre sensor 

 

Daniela Duc, Swinburne University of Technology, Australia

Fabrication of gold nanorod conjugated reduced graphene oxide for optical and electrical cell co-stimulation 

 

Xian Wen Tan, Okayama University, Japan

Natural Ameliorative Biomaterial for oxidative stress and inflammation 

 

3:25 - 3:45pm

Frost & Sullivan 

Room: Promenade

Report on the medtech sector

 

Mark Dougan, Consulting Director, Healthcare, Frost & Sullivan, Asia Pacific 

3:45 - 4:15pm

Afternoon tea

4:15 - 5:15pm

On the couch AusMedtech 2017 & ICMMB 2017 wrap-up session 

This session is a traditional wrap up session summarising the main outcomes raised during the conference and looks ahead at AusMedtech 2018

Room: Promenade

 

Co-Chair: Warren Bingham, VP Asia Pacific, Clinical Genomics

Co-Chair: Peter Bradley, VP Global Business Development, LBT Innovations

 

Dr Abby Bloom, Executive Chair, Acu Rate Pty Ltd 

Dr Kerry A. Hegarty, Business Development Director, Research, Innovation & Commercialisation, The University of Melbourne

Prof Yosry Morsi, Swinburne University of Technology, Australia

Prof Romano Zannoli, University of Bologna, Italy

 

5:15 - 6:15pm

Closing Drinks

Room: Promenade foyer area

supported by: